GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Labiana Health SA (XMAD:LAB) » Definitions » Pretax Margin %

Labiana Health (XMAD:LAB) Pretax Margin % : -22.93% (As of Dec. 2022)


View and export this data going back to 2022. Start your Free Trial

What is Labiana Health Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Labiana Health's Pre-Tax Income for the six months ended in Dec. 2022 was €-6.60 Mil. Labiana Health's Revenue for the six months ended in Dec. 2022 was €28.79 Mil. Therefore, Labiana Health's pretax margin for the quarter that ended in Dec. 2022 was -22.93%.

The historical rank and industry rank for Labiana Health's Pretax Margin % or its related term are showing as below:


XMAD:LAB's Pretax Margin % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 4.12
* Ranked among companies with meaningful Pretax Margin % only.

Labiana Health Pretax Margin % Historical Data

The historical data trend for Labiana Health's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Labiana Health Pretax Margin % Chart

Labiana Health Annual Data
Trend Dec20 Dec21 Dec22
Pretax Margin %
0.94 -3.73 -13.55

Labiana Health Semi-Annual Data
Dec20 Dec21 Jun22 Dec22
Pretax Margin % - - -4.26 -22.93

Competitive Comparison of Labiana Health's Pretax Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Labiana Health's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Labiana Health's Pretax Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Labiana Health's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Labiana Health's Pretax Margin % falls into.



Labiana Health Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Labiana Health's Pretax Margin for the fiscal year that ended in Dec. 2022 is calculated as

Pretax Margin=Pre-Tax Income (A: Dec. 2022 )/Revenue (A: Dec. 2022 )
=-7.84/57.848
=-13.55 %

Labiana Health's Pretax Margin for the quarter that ended in Dec. 2022 is calculated as

Pretax Margin=Pre-Tax Income (Q: Dec. 2022 )/Revenue (Q: Dec. 2022 )
=-6.601/28.787
=-22.93 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Labiana Health  (XMAD:LAB) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


Labiana Health Pretax Margin % Related Terms

Thank you for viewing the detailed overview of Labiana Health's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Labiana Health (XMAD:LAB) Business Description

Traded in Other Exchanges
N/A
Address
Avenida Europa, 34 1st D, Pozuelo de Alarcon, Madrid, ESP, 28023
Labiana Health SA is a manufacturer of pharmacological products for veterinary use. The company's activities include GMP manufacturer for EU animal and human health industries, manufacturer specialized in sterile and lyophilized dosage forms, source of development, acquisition, and licensing of molecules such as Fosfomycin Trometamol.